COVID-19 has reached many sub-Saharan African countries that are already suffering from malnutrition and disease, under-resourced health systems, and limited economic funding. Richard Marlink, director of Rutgers Global Health Institute and a leader in the global response to HIV/AIDS, discusses how this pandemic is likely to impact the African region and what can be done to help these countries.
In an op-ed for the Star-Ledger, Richard Marlink discusses the need to address cancer care and prevention disparities in sub-Saharan Africa, where aging HIV-positive populations face an increased risk of certain cancers.
During a seminar with the Rutgers cohort of 25 young African leaders, institute director Richard Marlink led a discussion about mobilizing three essential strategies to end the epidemic: follow the science, treat the whole person, and expand the health care workforce.
Programs to prevent HIV in transgender women are helping to lower the rate of new infection, but better care and treatment of this vulnerable population are still needed, especially among those with lower income or people of color, according to a study led by core faculty member Henry Raymond, an associate professor at the School of Public Health.
Healio.com’s Infectious Disease News spoke with institute director Richard Marlink, MD, who treated some of the first HIV/AIDS patients at St. Vincent’s Hospital in New York and helped establish the first HIV/AIDS clinic in Boston. In this interview marking the 30th anniversary of World AIDS Day, Marlink discusses the likelihood of a cure and vaccine, federal funding, testing among high-risk populations, PrEP, stigma, and medical treatment.